Rules › CMS-2023-0092

Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program

Proposed rule from the Health and Human Services Department, Centers for Medicare & Medicaid Services (docket CMS-2023-0092). 98 comment letters from companies and organizations are listed below.

Agency

Health and Human Services Department, Centers for Medicare & Medicaid Services

Docket

CMS-2023-0092

Published

2023-05-26

Comments due

2023-07-25

Status

Comment period closed July 25, 2023 · no final rule found yet

Total public comments

134

Letters listed here

98

Joint letters

1, adding 6 more organizations as co-signers

Federal Register notice ↗ · Docket on Regulations.gov ↗

Who commented, by industry

Pharma & Medical Devices 37 Healthcare 28 Other 13 Advocacy & Nonprofits 10 Insurance 4 Business Groups & Chambers 2 Law, Accounting & Consulting 1 Government & Tribes 1 Environment & Conservation 1 Education 1

Who commented